Who is sponsoring NCT04117750?

NCT04117750 is sponsored by Zagazig University.

What drugs are being tested in NCT04117750?

Interventions in NCT04117750: cholecalciferol (vit D3).

What condition does NCT04117750 study?

NCT04117750 studies Evaluations, Diagnostic Self, Treatment Adherence.

Is NCT04117750 still recruiting?

NCT04117750 is currently completed. Last updated 8 October 2019.

Last reviewed 2019-10-08 · How we verify

NCT04117750

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Impact of Vitamin D Supplementation on Cardiometabolic Status and Androgen Profile in Polycystic Ovary Syndrome

Completed NA Last updated 8 October 2019

What this trial tests

NA trial testing cholecalciferol (vit D3) in Evaluations, Diagnostic Self in 145 participants. Completed in 1 July 2018.

Timeline

1 November 2017

Primary endpoint
1 April 2018

1 July 2018

Quick facts

Lead sponsor	Zagazig University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	diagnostic
Enrollment	145
Start date	1 November 2017
Primary completion	1 April 2018
Estimated completion	1 July 2018
Sites	1 location across Egypt

Drugs / interventions tested

cholecalciferol (vit D3) — full drug profile →

Conditions studied

Evaluations, Diagnostic Self — all drugs for Evaluations, Diagnostic Self →
Treatment Adherence — all drugs for Treatment Adherence →

Sponsor

Zagazig University

Who can join

Adults 20 to 33, female only, with Evaluations, Diagnostic Self or Treatment Adherence. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Polycystic ovary syndrome (PCOS) is a heterogeneous disorder of reproductive, endocrine and metabolic functions. Vitamin D has an influence on metabolic and reproductive functions. This study was designed to explore the levels of free 25 hydroxy cholecalciferol \[25(OH) D\] in PCOS patients. We also aimed to clarify the impact of vitamin D supplementation on cardiometabolic status, androgen profile and clinical features of PCOS.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Zagazig University trials

Trials by the same sponsor.

NCT07423676 — Comparison Between Two Drugs in Sedation of Upper GI Endoscopy · not yet recruiting
NCT07418307 — Comparison Between Combined Biceps Femoris Short Head Block and Adductor Canal Block Versus Genicular Nerve Block · NA · not yet recruiting
NCT07435025 — Surgery for Obstructed Gastric Carcinoma · NA · active not recruiting
NCT07330375 — Effect of Intravenous Dexmedetomidine and Ketamine on Post-Operative Analgesia · Phase 3 · not yet recruiting
NCT07309731 — Impact OF Cooled Versus Thermal Radiofrequency Denervation In Management Of Chronic Lumber Facet Joint Pain · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04117750 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Zagazig University
Last refreshed: 8 October 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04117750.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing